TrademarkDir
MEDILYMER
LIVE

Serial Number

99098664

Owner

Ju Hee KIM

Attorney

Eunyoung Lee

First Use Date

Jun 23, 2025

Filing Date

Mar 22, 2025

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MEDILYMER Trademark

Serial Number: 99098664 • Registration: 8318561

MEDILYMER is a trademark filed by Ju Hee KIM on March 22, 2025. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Ju Hee KIM (2 trademarks)

223-12, Galmaji-gil
Dongducheon-si, Gyeonggi-do 11340 , KR

Entity Type: 01

Trademark Details

Filing Date

March 22, 2025

Registration Date

June 23, 2026

First Use Anywhere

June 23, 2025

First Use in Commerce

June 23, 2025

Published for Opposition

September 23, 2025

Goods & Services

Supports for elbow for medical use

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 23, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 2, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 2, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 23, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 23, 2026 AITU
USE AMENDMENT FILED
Jan 20, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 20, 2026 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 18, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 21, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 21, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 21, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 21, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 21, 2025 CNEA
ASSIGNED TO EXAMINER
Aug 21, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 22, 2025 MAFR
NEW APPLICATION ENTERED
Mar 22, 2025 NWAP

Related Trademarks

More from this Owner

BRVX

BRVX